Elfunat (ethylmethylhydroxypyridine succinate) solution for injections 50 mg/ml. 2 ml. №10


Manufacturer: USA



Acute disorders of cerebral circulation; traumatic brain injury, consequences of traumatic brain injuries; dyscirculatory encephalopathy; neurocirculatory dystonia; mild cognitive disorders of atherosclerotic origin; anxiety disorders in neurotic and neurosis-like conditions; acute myocardial infarction (from the first day) as part of complex therapy; primary open-angle glaucoma of various stages, as part of complex therapy; relief of withdrawal syndrome in alcoholism with a predominance of neurosis-like and neurocirculatory disorders; acute intoxication with antipsychotic agents; acute purulent-inflammatory processes in the abdominal cavity (acute necrotic pancreatitis, peritonitis) as part of complex therapy.